Zoe Bollinger
Sep 1, 2015
Pharma Backed Patent Law Change Would Raise Medicare Costs
A patent law change sought by the pharmaceutical industry could cost federal health-care programs $1.3 billion over a decade by delaying new generic medicines, an analysis by the Congressional Budget Office found this summer